Clinical Trials Directory

Trials / Completed

CompletedNCT05824026

Investigation of the Clinical Performance of Biatain Fiber Ag on Burns

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Coloplast A/S · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to test a new gelling fiber wound dressing with silver on patients with a partial thickness burn wound, which is infected or at risk of infection. Participants will be asked to wear the test dressing in a two weeks period(+/- 2 days) consisting of 3-4 study visits, and will have the dressing changed once pr. week at the research facility. The wound will be cleaned, assessed and photos will be uploaded to a digital software system.

Detailed description

The clinical investigation is a non-comparative, one-armed, open-labelled, multi-centre study. The test product, Biatain Fiber Ag is a non-CE-marked gelling fiber wound dressing, containing silver. The product is intended for moist wound healing and exudate management of moderate to high exuding wounds. The product has a classification III, as it contains the active ingredient silver. The overall purpose of this investigation is to obtain clinical data supporting effectiveness of Biatain Fiber Ag to obtain the CE-mark in EU. The total study duration for the subject will be approximately two weeks (+/- 2 days), consisting of a two-week test period and 4 study visits (V0/V1, V2 and V3). V3 will also terminate the 2-week study period. The primary endpoint is percentage of wounds healed within 14 days (≥ 95 % reepithelialisation) The clinical investigation will be conducted in a total of 50 eligible subjects with a partial thickness burn wound that are infected or at risk of infection.

Conditions

Interventions

TypeNameDescription
DEVICEGelling fiber wound dressing with silverintervention involving a wound dressing with silver

Timeline

Start date
2023-10-27
Primary completion
2024-04-26
Completion
2024-04-26
First posted
2023-04-21
Last updated
2025-09-11
Results posted
2025-09-11

Locations

5 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05824026. Inclusion in this directory is not an endorsement.